(lp0
S"Supernus Pharmaceuticals Inc.  Breaks into New 52-Week High on March 28 ... Equities.com - 9 hours ago Shares of Supernus Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $31.35. Shares closed at $30.85 after opening at $30.90 for a move of 0.16%.Supernus Pharmaceuticals'  Buy Rating Reiterated at Jefferies Group LLC - Chaffey BreezeAnalyst's Predictions on TerraForm Global, Inc. , Supernus ... - StockNewsJournal"
p1
aS'Supernus: Label Expansion, Trokendi Settlement Catalysts For More Upside Seeking Alpha - Mar 16, 2017 The company guided for 2017 sales in the $265-275 million range, which is right in line with my estimate range for the year.'
p2
aS'Stock Volatility Risk Alert: Supernus Pharmaceuticals Inc Price Volatility ... CML News - 19 hours ago Before we dive into any analysis we simply note that Supernus Pharmaceuticals Inc  has seen its stock price whip around at a towering high level.'
p3
aS'Investor Spotlight on Shares of Supernus Pharmaceuticals, Inc.  Rives Journal - 9 hours ago Individual investors might be studying multiple metrics in order to maximize returns. Supernus Pharmaceuticals, Inc.'
p4
aS'Supernus Pharmaceuticals Inc.  Soars 5.38% on March 02 Equities.com - Mar 2, 2017 Supernus Pharmaceuticals Inc.  had a good day on the market for Thursday March 02 as shares jumped 5.38% to close at $27.40.'
p5
aS'Supernus Pharmaceuticals Inc.  Soars 5.3% on March 08 Equities.com - Mar 8, 2017 Supernus Pharmaceuticals Inc.  had a good day on the market for Wednesday March 08 as shares jumped 5.3% to close at $27.80.'
p6
aS'Supernus Pharmaceuticals Inc Realized Volatility Hits An Extraordinary High CML News - Mar 13, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for Supernus Pharmaceuticals Inc  . We examine the little used gem of daily stock volatility over ...Jefferies Group LLC Boosts Supernus Pharmaceuticals Inc  Price Target to ... - BNB Daily Cantor Fitzgerald Reaffirms Overweight Rating for Supernus Pharmaceuticals ... - The Cerbat Gem'
p7
aS'Supernus Pharmaceuticals,Inc.  Files An 8-K Entry into a Material ... Market Exclusive - Mar 9, 2017 On March 6, 2017, Supernus Pharmaceuticals, Inc.  entered into a binding term sheet  with Actavis Laboratories, FL, Inc., Actavis Pharma, Inc., and Watson Laboratories, Inc. (collectively, Actavis, now a&nbsp;...'
p8
aS'Cadila inks pact with Supernus Pharma to settle patent issue Economic Times - Mar 7, 2017 Cadila Healthcare, along with subsidiary Zydus Pharmaceuticals  Inc, have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation related to Trokendi XR  extended-release capsules, Cadila&nbsp;...Analyst Activity  Cantor Fitzgerald Reiterates Buy on Supernus ... - Market ExclusiveSupernus Announces Settlement with Zydus on Trokendi XR Patent Litigation - GlobeNewswire '
p9
aS'Supernus Pharmaceuticals, Inc.  Stock Analysis &amp; Valuation Update Business Review - Mar 28, 2017 Supernus Pharmaceuticals, Inc.  has a Q.i. Value of 47.00000. The Q.i. Value ranks companies using four ratios.'
p10
a.